FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as monotherapy for adults with treatment-resistant depression, Johnson & Johnson announced in a press release.
Geriatric Depression Scale (GDS). Recent Evidence and Development ... Best Practices in Nursing Care to Older Adults," developed by the Hartford Institute for Geriatric Nursing.
A study published in Journal of American Geriatrics Society on Wednesday finds that older adults face lower odds for depression if they didn’t have depression earlier in life or had higher income ...
News Medical on MSN15d
Research highlights depression trends in community-dwelling older adultsOlder adults who had a negative history of depression or had ... The Patient-Reported Outcomes Measurement Information System (PROMIS®) depression scale was used to determine the depression ...
Marked variation in the prevalence of depression was found in a multisite sample of community-dwelling older adults in the United States, reports a study by Columbia University Mailman School of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback